| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 08/04/2004 | EP1189875B1 Mono and multifunctional alkoxyamines for the preparation of functionalized macromers |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | CN1518544A Piperazine derivative, process for producing the same, polymeric solid electrolyte and secondary battery |
| 08/04/2004 | CN1518541A Phenyl derivatives |
| 08/04/2004 | CN1518534A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160335C Method for joint production of cyclic lactam and cyclic amine |
| 08/04/2004 | CN1160329C O-thiocarbamoyl-aminoalkanol copmound, their pharmaceutically acceptable salt and process for preparing the same |
| 08/04/2004 | CN1160309C Alkyloxyamino substitued fluorenones and their use as protein kinase C inhibitors |
| 08/04/2004 | CN1160308C Deallylation reagent and deallylation method using said reagent |
| 08/04/2004 | CN1160052C Amino substituted hydroxy-diphenylone as light stability ultraviolet fitering agent used in cosmetic and pharmaceutical preparation |
| 08/03/2004 | US6770650 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 08/03/2004 | US6770649 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 08/03/2004 | US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
| 08/03/2004 | US6770636 Phenyl-and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 08/03/2004 | US6770627 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p 53 |
| 08/03/2004 | US6770588 A reductive system including a silane, preferably pmhs, and an active zinc compound, which is monomeric and not a hydride, wherein a reduction of a carbonyl substrate to a corresponding alcohol is achievable. |
| 08/03/2004 | CA2136836C Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 08/03/2004 | CA2121065C External anti-inflammatory and analgesic plaster preparation |
| 07/29/2004 | WO2004063181A1 Urea derivatives and their use as anti-inflammatory agents |
| 07/29/2004 | WO2004063180A1 Substituted heterocyclic compounds |
| 07/29/2004 | WO2004063163A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/29/2004 | WO2004063150A2 Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
| 07/29/2004 | WO2004062601A2 Antibacterial agents |
| 07/29/2004 | WO2004062594A2 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon |
| 07/29/2004 | WO2004047743A3 1-aryl-2-hydroxyethyl amides as potassium channel openers |
| 07/29/2004 | WO2004046091A3 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004026816B1 Aromatic liver x-receptor modulators |
| 07/29/2004 | US20040147753 Reacting 1-(bicyclo-[2.2.1]hept-5-en-2-yl)-3-piperidino-1-propanone with phenylmagnesium compound; salt formation, solvent extraction, crystallization; high yield |
| 07/29/2004 | US20040147746 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147575 Hypotensive agents; cardiovascular disorders |
| 07/29/2004 | US20040147570 Substituted 1 and 2-naphthol mannich bases |
| 07/29/2004 | US20040147569 Cell differentiation inducer |
| 07/29/2004 | US20040147559 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/29/2004 | US20040147529 Preferentially substituted calcium channel blockers |
| 07/29/2004 | US20040147526 Analgesics; anxiolytic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147494 Use |
| 07/29/2004 | US20040147454 Aspartyl protease inhibitors |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/29/2004 | CA2512261A1 Substituted heterocyclic compounds |
| 07/29/2004 | CA2512257A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands |
| 07/28/2004 | EP1440118A1 Blends of waxes and polymer additives |
| 07/28/2004 | EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/28/2004 | EP1137632B1 Thiourea inhibitors of herpes viruses |
| 07/28/2004 | EP0979064B1 Oxidation colorants |
| 07/28/2004 | CN1516697A Aromatic dicarboxylic acid derivatives |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1515563A Aryl substituted piperazine for curing benign prostatauxe |
| 07/28/2004 | CN1515561A Method for producing chiral succinic acid derivative |
| 07/28/2004 | CN1515556A Intermediate compound for preparing aryl substituted piperazine |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515256A Application of estrogen antagonist and estrogen excitent for inhibiting pathological disease |
| 07/28/2004 | CN1159293C 5-aroylnaphthalene derivatives |
| 07/28/2004 | CN1159278C Fungicidal methods, compounds and compositions contg. benzophenones |
| 07/28/2004 | CN1159277C New intermediate for preparation of anti-histamine piperdine derivatives |
| 07/27/2004 | US6768024 Triamine derivative melanocortin receptor ligands and methods of using same |
| 07/27/2004 | US6767907 For therapy of psychic and neurologic disorders |
| 07/27/2004 | CA2118512C Agents for treating substance abuse disorders |
| 07/27/2004 | CA2103861C Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines |
| 07/22/2004 | WO2004061084A2 Modulation of protein functionalities |
| 07/22/2004 | WO2004060862A2 Compounds having prolyl oligopeptidase inhibitory activity |
| 07/22/2004 | WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/22/2004 | WO2004060306A2 Anti-inflammatory medicaments |
| 07/22/2004 | WO2004060305A2 Anti-cancer medicaments |
| 07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/22/2004 | US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst |
| 07/22/2004 | US20040142999 Novel compounds and compositions as cathepsin inhibitors |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142984 Applying to plants |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142981 Sterilization, antiseptics for bacteria infections |
| 07/22/2004 | US20040142963 Cardiovascular disorders |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142909 Colchinol derivatives as angiogenesis inhibitors |
| 07/22/2004 | CA2513627A1 Anti-inflammatory medicaments |
| 07/22/2004 | CA2511873A1 Modulation of protein functionalities |
| 07/22/2004 | CA2511856A1 Compounds having prolyl oligopeptidase inhibitory activity |
| 07/22/2004 | CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators |
| 07/21/2004 | EP1439187A1 O2-Arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
| 07/21/2004 | EP1438302A1 New sulfonamide derivatives as d3-receptor agonists |
| 07/21/2004 | EP1438298A1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 07/21/2004 | EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 07/21/2004 | EP1438288A1 Substituted thioacetamides |
| 07/21/2004 | EP1147080B1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP1051143B1 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives |
| 07/21/2004 | CN1158274C Benzopyran-containing compounds and method for their use |
| 07/21/2004 | CN1158270C Bipiperazine derivatives with calcium ion antagon action |
| 07/21/2004 | CN1158260C Solid compound, preparation method therefor and use in medicine |
| 07/20/2004 | US6765093 4-(3-amino-2-hydroxypropoxy)-m-phenylenediamine couplers; 3-amino group is optionally substituted |
| 07/20/2004 | US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 07/20/2004 | US6765021 Antidiabetic agents |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6764613 For use in bleaching and cleaning |
| 07/20/2004 | CA2257136C Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |